• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喉鳞状细胞癌患者血浆中 microRNAs 的差异表达:喉鳞状细胞癌的潜在早期检测标志物。

Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma.

机构信息

Department of Biochemistry, Faculty of Pharmacy, Trakya University, Edirne, 22030, Turkey.

出版信息

J Cancer Res Clin Oncol. 2013 Sep;139(9):1499-506. doi: 10.1007/s00432-013-1469-2. Epub 2013 Jul 2.

DOI:10.1007/s00432-013-1469-2
PMID:23817697
Abstract

PURPOSE

Altered microRNA (miRNA) expression has been found in many cancers, including lung, breast, prostate, bladder and colorectal cancer. Many recent studies have demonstrated that aberrant plasma miRNAs were also found in various types of cancers. However, the alteration in plasma miRNA expressions in laryngeal squamous cell carcinoma (LSCC) remains unclear. The present study aimed to investigate the alterations in plasma miRNAs in LSCC.

METHODS

In the present study, the expression profiles of 738 miRNAs in plasma from 20 patients and 44 healthy subjects were evaluated using high-throughput real-time quantitative polymerase chain reaction.

RESULTS

Our results demonstrated that expression levels of 17 miRNAs were significantly upregulated in patients with LSCCs when compared to control group (p < 0.05). Expression levels of nine miRNAs were found significantly downregulated in LSCC patients (p < 0.05). In addition, 17 miRNAs were expressed only in LSCC group, and five of these miRNAs (miR-331-3p, 603, 1303, 660-5p and 212-3p) are LSCC specific and never seen before in plasma of any human subject.

CONCLUSION

In conclusion, our study suggests that detecting these LSCC-specific miRNAs in plasma might serve as novel noninvasive biomarkers for LSCC.

摘要

目的

已在多种癌症中发现微小 RNA(miRNA)表达异常,包括肺癌、乳腺癌、前列腺癌、膀胱癌和结直肠癌。许多最近的研究表明,各种类型的癌症中也存在异常的血浆 miRNA。然而,喉鳞状细胞癌(LSCC)中血浆 miRNA 表达的改变尚不清楚。本研究旨在探讨 LSCC 中血浆 miRNA 的变化。

方法

在本研究中,使用高通量实时定量聚合酶链反应评估了 20 例患者和 44 例健康受试者血浆中 738 种 miRNA 的表达谱。

结果

我们的结果表明,与对照组相比,LSCC 患者的 17 种 miRNA 表达水平显著上调(p<0.05)。在 LSCC 患者中发现 9 种 miRNA 的表达水平显著下调(p<0.05)。此外,17 种 miRNA 仅在 LSCC 组中表达,其中 5 种 miRNA(miR-331-3p、603、1303、660-5p 和 212-3p)是 LSCC 特异性的,以前从未在任何人类受试者的血浆中发现过。

结论

总之,我们的研究表明,检测这些 LSCC 特异性 miRNA 在血浆中可能作为 LSCC 的新型非侵入性生物标志物。

相似文献

1
Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma.喉鳞状细胞癌患者血浆中 microRNAs 的差异表达:喉鳞状细胞癌的潜在早期检测标志物。
J Cancer Res Clin Oncol. 2013 Sep;139(9):1499-506. doi: 10.1007/s00432-013-1469-2. Epub 2013 Jul 2.
2
VEGFA (rs1570360, rs699947, rs3025033, rs2146323, rs3024997) genotypes in patients with laryngeal squamous cell carcinoma.喉鳞状细胞癌患者的VEGFA(rs1570360、rs699947、rs3025033、rs2146323、rs3024997)基因型。
BMC Cancer. 2025 Jul 1;25(1):1132. doi: 10.1186/s12885-025-14536-8.
3
The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma.微小RNA-155在人喉鳞状细胞癌血浆和组织中的表达具有相关性。
Yonsei Med J. 2016 Mar;57(2):298-305. doi: 10.3349/ymj.2016.57.2.298.
4
[Predictive Value of miRNAs Markers for Advanced Lung Squamous Cell Carcinoma].[微小RNA标志物对晚期肺鳞状细胞癌的预测价值]
Zhongguo Fei Ai Za Zhi. 2025 May 20;28(5):325-333. doi: 10.3779/j.issn.1009-3419.2025.102.16.
5
Plasma-derived Exosomal miR-25-3p and miR-23b-3p as Predictors of Response to Chemoradiotherapy in Esophageal Squamous Cell Carcinoma.血浆衍生外泌体 miR-25-3p 和 miR-23b-3p 作为预测食管鳞癌放化疗反应的标志物。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241289520. doi: 10.1177/15330338241289520.
6
MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis.人原发性鳞状细胞肺癌中 miR-21 的过表达与患者预后不良相关。
J Cancer Res Clin Oncol. 2011 Apr;137(4):557-66. doi: 10.1007/s00432-010-0918-4. Epub 2010 May 28.
7
m6A/HOXA10-AS/ITGA6 axis aggravates oxidative resistance and malignant progression of laryngeal squamous cell carcinoma through regulating Notch and Keap1/Nrf2 pathways.m6A/HOXA10-AS/ITGA6 轴通过调节 Notch 和 Keap1/Nrf2 通路加重喉鳞状细胞癌的氧化抵抗和恶性进展。
Cancer Lett. 2024 Apr 10;587:216735. doi: 10.1016/j.canlet.2024.216735. Epub 2024 Feb 17.
8
Serum extracellular vesicle microRNAs as potential biomarkers to predict pembrolizumab response and prognosis in metastatic non-small cell lung cancer patients.血清细胞外囊泡微小RNA作为预测转移性非小细胞肺癌患者帕博利珠单抗反应和预后的潜在生物标志物。
Front Immunol. 2025 Jun 4;16:1540906. doi: 10.3389/fimmu.2025.1540906. eCollection 2025.
9
SELDI-TOF MS profiling of serum for detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis.用于检测喉鳞状细胞癌及进展至淋巴结转移的血清表面增强激光解吸电离飞行时间质谱分析
J Cancer Res Clin Oncol. 2008 Jul;134(7):769-76. doi: 10.1007/s00432-007-0344-4. Epub 2008 Jan 17.
10
Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC).喉鳞状细胞癌(LSCC)患者血清中选定 miRNA 的表达。
Diagn Pathol. 2019 May 28;14(1):49. doi: 10.1186/s13000-019-0823-3.

引用本文的文献

1
The microRNA-6510 as a potential tumor suppressor in head and neck cancer.微小RNA-6510作为头颈癌中一种潜在的肿瘤抑制因子。
Sci Rep. 2025 Feb 18;15(1):5830. doi: 10.1038/s41598-025-86796-0.
2
A Systematic Review of Circulating miRNAs Validated by Multiple Independent Studies in Laryngeal Cancer.一项关于经多项独立研究验证的喉癌循环微小RNA的系统评价。
Diagnostics (Basel). 2025 Feb 6;15(3):394. doi: 10.3390/diagnostics15030394.
3
Identification and bioinformatic characterization of a serum miRNA signature for early detection of laryngeal squamous cell carcinoma.

本文引用的文献

1
The distribution of circulating microRNA and their relation to coronary disease.循环微RNA的分布及其与冠心病的关系。
F1000Res. 2012 Nov 19;1:50. doi: 10.12688/f1000research.1-50.v1. eCollection 2012.
2
Four serum microRNAs identified as diagnostic biomarkers of sepsis.四种血清 microRNAs 被鉴定为败血症的诊断生物标志物。
J Trauma Acute Care Surg. 2012 Oct;73(4):850-4. doi: 10.1097/TA.0b013e31825a7560.
3
Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
鉴定和生物信息学分析用于早期检测喉鳞癌的血清 miRNA 特征。
J Transl Med. 2024 Jul 10;22(1):647. doi: 10.1186/s12967-024-05385-3.
4
Laryngeal cancer diagnosis via miRNA-based decision tree model.通过基于微小RNA的决策树模型诊断喉癌
Eur Arch Otorhinolaryngol. 2024 Mar;281(3):1391-1399. doi: 10.1007/s00405-023-08383-1. Epub 2023 Dec 26.
5
Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy.循环微RNA作为口腔癌液体活检中的生物标志物
Biomedicines. 2023 Mar 21;11(3):965. doi: 10.3390/biomedicines11030965.
6
Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review.微小RNA在喉癌患者中的诊断和预后价值:一项系统评价
Noncoding RNA. 2023 Jan 19;9(1):9. doi: 10.3390/ncrna9010009.
7
Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.头颈部癌症中有前景的生物标志物:最具临床意义的 miRNAs。
Int J Mol Sci. 2022 Jul 26;23(15):8257. doi: 10.3390/ijms23158257.
8
m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Cell-Infiltration Characterization in Head and Neck Cancer.m6A调控因子介导的甲基化修饰模式及头颈癌肿瘤微环境细胞浸润特征
Front Cell Dev Biol. 2022 Feb 7;9:803141. doi: 10.3389/fcell.2021.803141. eCollection 2021.
9
Multiple microRNA signature panel as promising potential for diagnosis and prognosis of head and neck cancer.多 miRNA 特征面板对头颈癌的诊断和预后具有很大的潜力。
Mol Biol Rep. 2022 Feb;49(2):1501-1511. doi: 10.1007/s11033-021-06954-1. Epub 2021 Nov 27.
10
Head and Neck Cancers Are Not Alike When Tarred with the Same Brush: An Epigenetic Perspective from the Cancerization Field to Prognosis.头颈癌不能一概而论:从癌化场到预后的表观遗传学视角
Cancers (Basel). 2021 Nov 11;13(22):5630. doi: 10.3390/cancers13225630.
miRNA 特征在子宫内膜样腺癌患者组织和血浆中的诊断和预后意义。
Int J Cancer. 2013 Apr 1;132(7):1633-45. doi: 10.1002/ijc.27840. Epub 2012 Oct 17.
4
Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK.下调皮肤鳞状细胞癌中的 miR-124/-214 通过诱导 ERK 介导异常细胞增殖。
J Mol Med (Berl). 2013 Jan;91(1):69-81. doi: 10.1007/s00109-012-0935-7. Epub 2012 Jul 25.
5
Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma.喉鳞状细胞癌中 microRNAs 的全面表达谱分析。
Head Neck. 2013 May;35(5):720-8. doi: 10.1002/hed.23011. Epub 2012 May 18.
6
Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma.循环 microRNA 表达与多发性骨髓瘤的遗传亚型和生存相关。
Med Oncol. 2012 Dec;29(4):2402-8. doi: 10.1007/s12032-012-0210-3. Epub 2012 Mar 24.
7
Altered expression of miR-21 and PTEN in human laryngeal and hypopharyngeal squamous cell carcinomas.miR-21和PTEN在人喉及下咽鳞状细胞癌中的表达改变
Asian Pac J Cancer Prev. 2011;12(10):2653-7.
8
MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin.微小 RNA-203 通过直接靶向生存素导致喉癌细胞 G1 期细胞周期停滞。
FEBS Lett. 2012 Mar 23;586(6):804-9. doi: 10.1016/j.febslet.2012.01.050. Epub 2012 Feb 1.
9
A panel of five circulating microRNAs as potential biomarkers for prostate cancer.五组循环 microRNAs 作为前列腺癌潜在的生物标志物。
Prostate. 2012 Sep 15;72(13):1443-52. doi: 10.1002/pros.22495. Epub 2012 Feb 1.
10
Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer.循环 miR-18a 在胰腺癌患者血浆中的诊断新价值。
Br J Cancer. 2011 Nov 22;105(11):1733-40. doi: 10.1038/bjc.2011.453. Epub 2011 Nov 1.